Large Pharma operating as a small family owned company - Executive Director Boehringer Ingelheim Employee Review

Weak HR and poor talent management; pay for high performers lagging behind industry leaders, key promotions in general not based on solid experience or a consistent track record of performance, no consistent way of recognizing good performance or behaviors, no direct accountability for people development, no decisions (the important ones) allowed below the board level, poor cross functional alignment, weak collaboration between the US and corporate; profit sharing restricted to an exclusive few (less than 1 percent of employees)